Pisanu Adolfo, Cois Alessandro, Montisci Alessandro, Uccheddu Alessandro
Dipartimento Chirurgico, Materno-Infantile e di Scienze dell'Immagine-Semeiotica Chirurgica, Centro di Studio per la Chirurgia Laparoscopica Avanzata in Chirurgia Generale, Università degli Studi di Cagliari.
Chir Ital. 2004 May-Jun;56(3):313-20.
The aim of this study was to clarify the current indications for laparoscopic adrenalectomy, reviewing both our own experience and the literature data. Since January 2000, 22 patients have undergone adrenalectomy in our department: 17 (77.3%) with the laparoscopic approach and 5 (22.7%) with the traditional one. The indications for laparoscopy were: 6 Cushing's adenomas, 4 aldosterone-producing adenomas, 4 non-functional adenomas, 2 pituitary-dependent bilateral adrenocortical hyperplasias and 1 metachronous adrenal metastasis. The conversion rate to laparotomy was 11.7%. The indications for the open approach were: tumours greater than 7 cm and previous abdominal surgery. The mean size of laparoscopic specimens was smaller than those removed by the open procedure (3.9 cm versus 6.7 cm). The mean postoperative hospital stay in the laparoscopic group was 4.9 days as compared to 10.2 days in the open group. Morbidity was encountered in 2/17 laparoscopically treated patients (11.7%) and in 2/5 patients in the open group. In our early experience, laparoscopic adrenalectomy has been the procedure of choice for removing unilateral or bilateral tumours measuring less than 7 cm in diameter. Nevertheless, apart from diameter cut-off, on the basis of evidence from the literature, an invasive carcinoma is currently considered the only absolute contraindication to laparoscopy.
本研究的目的是通过回顾我们自己的经验和文献数据,阐明目前腹腔镜肾上腺切除术的适应证。自2000年1月以来,我科共有22例患者接受了肾上腺切除术:17例(77.3%)采用腹腔镜手术,5例(22.7%)采用传统手术。腹腔镜手术的适应证包括:6例库欣腺瘤、4例醛固酮瘤、4例无功能腺瘤、2例垂体依赖性双侧肾上腺皮质增生和1例异时性肾上腺转移瘤。中转开腹率为11.7%。开放手术的适应证为:肿瘤直径大于7 cm以及既往有腹部手术史。腹腔镜手术切除标本的平均大小小于开放手术切除的标本(3.9 cm对6.7 cm)。腹腔镜组患者术后平均住院时间为4.9天,而开放组为10.2天。腹腔镜治疗的17例患者中有2例(11.7%)出现并发症,开放组5例患者中有2例出现并发症。在我们早期的经验中,腹腔镜肾上腺切除术一直是切除直径小于7 cm的单侧或双侧肿瘤的首选手术方式。然而,除了直径界限外,根据文献证据,目前侵袭性癌被认为是腹腔镜手术唯一的绝对禁忌证。